GlassScriptPhysician profile
Adham Khalafallah
NPI 1346829785
$5,051.66
in general payments reported to CMS, 2019-2025
5 companies · $2,636 in 2025
The $2,636 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $134 · 2023: $161 · 2024: $2,120 · 2025: $2,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,288 · Travel and Lodging: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,287.88 |
| Travel and Lodging | $1,629.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $2,657.03 | 2024-2025 | Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm |
| Stryker Corporation | $1,658.57 | 2023-2025 | Serrato, Capri Corpectomy Cage System, Everest Spinal System |
| Kuros Biosciences USA, INC | $262.85 | 2025 | Magnetos |
| Medical Device Business Services, INC. | $246.17 | 2024-2025 | Symphony, Teligen |
| Vb Spine LLC | $92.73 | 2025 | Everest Spinal System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adham Khalafallah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.